EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models

Kun Xiang iD, Ergang Wang, John Mantyh, Gabrielle Rupprecht, Marcos Negrete, Golshid Sanati, Carolyn Hsu, Peggy Randon, Anders Dohlman, Kai Kretzschmar, Shree Bose, Nicholas Giroux und 17 weitere

Advanced Science · 2024-04 · 11 (16)

DOI: 10.1002/advs.202303379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.02.2024. Verfasst von Kun Xiang und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, 27708, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Chromatin Assembly and Disassembly, Organoids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient‐Derived Organoids (PDO) and Xenografts (PDX) are the current gold standards for patient‐derived models of cancer (PDMC). Nevertheless, how patient tumor cells evolve in these models and the impact on drug response remains unclear. Herein, the transcriptomic and chromatin accessibility landscapes of matched colorectal cancer (CRC) PDO, PDX, PDO‐derived PDX (PDOX), and original patient tumors (PT) are compared. Two major remodeling axes are discovered. The first axis delineates PDMC from PT, and the second axis distinguishes PDX and PDO. PDOX are more similar to PDX than PDO, indicating the growth environment is a driving force for chromatin adaptation. Transcription factors (TF) that differentially bind to open chromatins between matched PDO and PDOX are identified. Among them, KLF14 and EGR2 footprints are enriched in PDOX relative to matched PDO, and silencing of KLF14 or EGR2 promoted tumor growth. Furthermore, EPHA4, a shared downstream target gene of KLF14 and EGR2, altered tumor sensitivity to MEK inhibitor treatment. Altogether, patient‐derived CRC cells undergo both common and distinct chromatin remodeling in PDO and PDX/PDOX, driven largely by their respective microenvironments, which results in differences in growth and drug sensitivity and needs to be taken into consideration when interpreting their ability to predict clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsChromatin Assembly and DisassemblyOrganoidsHumansMiceAnimalsDisease Models, Animal

Stichwörter der Autor:innen

ATAC‐seq, Colorectal Cancer (CRC)Patient‐Derived Models of Cancer (PDMC)Patient‐Derived Organoids (PDO)Patient‐Derived Xenografts (PDX)

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC, 27708, USA.
  • Department of Medicine, School of Medicine, Duke University, Durham, NC, 27710, USA.
  • Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, 27709, USA.
  • Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center (UMC) Utrecht, Uppsalalaan 8, Utrecht, CT, 3584, The Netherlands.
  • Mildred Scheel Early Career Centre (MSNZ) for Cancer Research Würzburg, University Hospital Würzburg, 97080, Würzburg, Germany.
  • Terasaki Institute, Los Angeles, CA, 90024, USA.

ORCID-Profile: Kun Xiang, Xiling Shen

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Xiang, K., Wang, E., Mantyh, J., Rupprecht, G., Negrete, M., Sanati, G., Hsu, C., Randon, P., Dohlman, A., Kretzschmar, K., Bose, S., Giroux, N., Ding, S., Wang, L., Balcazar, J. P., Huang, Q., Sundaramoorthy, P., Xi, R., McCall, S. J., …, & Shen, X. (2024). Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models. Advanced Science, 11(16). https://doi.org/10.1002/advs.202303379

Vancouver

Xiang K, Wang E, Mantyh J, Rupprecht G, Negrete M, Sanati G, et al. Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models. Advanced Science. 2024;11(16). doi:10.1002/advs.202303379

BibTeX
@article{Xiang2024,
  author = {Xiang, Kun and Wang, Ergang and Mantyh, John and Rupprecht, Gabrielle and Negrete, Marcos and Sanati, Golshid and Hsu, Carolyn and Randon, Peggy and Dohlman, Anders and Kretzschmar, Kai and Bose, Shree and Giroux, Nicholas and Ding, Shengli and Wang, Lihua and Balcazar, Jorge Prado and Huang, Qiang and Sundaramoorthy, Pasupathi and Xi, Rui and McCall, Shannon Jones and Wang, Zhaohui and Jiang, Chongming and Kang, Yubin and Kopetz, Scott and Crawford, Gregory E and Lipkin, Steven M and Wang, Xiao-Fan and Clevers, Hans and Hsu, David and Shen, Xiling},
  title = {Chromatin Remodeling in Patient‐Derived Colorectal Cancer Models},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {16},
  doi = {10.1002/advs.202303379}
}
Kostenlos starten →